Myeloma | Tumor

CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.

Sarclisa Delivered Through Under-the-Skin Injection Shows Promise in Patients With Pretreated Myeloma

September 1st 2022

Delivering Sarclisa via an under-the-skin injection may improve the quality of life of patients with pretreated relapsed, refractory multiple myeloma, according to recent research.

‘Mounting Evidence’ Suggests Exposure to Environmental Toxins Plays a Role in Onset of Myeloma, Says Expert

August 29th 2022

Firefighters and recovery workers exposed to the aftermath of 9/11 in New York City had a higher occurrence of MGUS, a condition which may progress to myeloma, according to recent research.

Addition of Empliciti to Combination Regimen Continues to Show Benefit in Previously Treated Multiple Myeloma

August 29th 2022

Long-term follow-up shows that treatment with Empliciti plus pomalidomide and dexamethasone continues to significantly increase survival rates in patients with relapsed or refractory multiple myeloma, a persistent cancer affecting white blood cells that may be resistant to treatment.

The Hub of Our Oncology Program

August 28th 2022

Lisa’s excellent fund of knowledge, experience in oncology, outstanding judgment and interest in learning all make her a truly outstanding clinician.

Use of Potentially Inappropriate Medications Associated With Increased Risks for Poor Outcomes in Older Patients With Cancer

August 11th 2022

The use of five or more medicines — as well as some drugs that could be deemed inappropriate — may put older patients with cancer at a higher risk for complications, such as weakness.

Abecma Improves Progression-Free Survival in Relapsed/Refractory Multiple Myeloma

August 10th 2022

Data from a clinical trial demonstrate a “clear clinical benefit” of using a CAR-T cell therapy in patients with multiple myeloma, according to the drugs manufacturer.

COVID-19 Booster Sparks Antibody Response in Patients With Blood Cancer Who Didn’t Benefit from Initial Vaccination

July 21st 2022

Findings from previous studies have shown that patients with blood cancers have been less likely to produce antibodies that protect them against COVID-19 after vaccination, but new research indicates that the booster shot may help.

New Drug Will Be Studied in Relapsed/Refractory Myeloma, Other Blood Cancers

July 6th 2022

The myeloma treatment group of the COVALENT-101 clinical trial recently started, analyzing the new drug BMF-219 in patients with relapsed or refractory disease.

Not Just My Oncology Nurse, But My Friend

July 4th 2022

She has helped me so much with my medications, and she always lifts me up when I need it most.

Teaching Others Through Cancer Advocacy

June 20th 2022

One patient turned her diagnosis of multiple myeloma into a way to educate others as an advocate.

Cancer Survivors May Be the Best Advocates

June 16th 2022

The best advocate for a patient with cancer is someone who knows exactly what they're going through, noted a multiple myeloma survivor.

Addition of Stem Cell Transplant Boosts Outcomes for Common Myeloma Regimen

June 10th 2022

Patients who underwent Revlimid, Velcade, and dexamethasone therapy followed by maintenance Revlimid, tended to have better outcomes when they underwent autologous stem cell transplant.

Adding Darzalex to Popular Multiple Myeloma Treatment Regimen May Lead to Durable Responses

June 7th 2022

Patients with multiple myeloma were more likely to have no traceable amounts of disease left when Darzalex was added to a treatment regimen of Revlimid, Velcade and dexamethasone.

Trial Kicks Off to Study Experimental CAR-T Cell Therapy in Myeloma

May 18th 2022

The hope, according to an expert, is that this trial will expand CAR-T cell therapy access to more patients with multiple myeloma.

Sarclisa-Containing Treatment Regimen Shows ‘Remarkable’ Results for Relapsed Myeloma

May 17th 2022

The combination of Sarclisa, Kyprolis and dexamethasone improved progression-free survival in patients with pretreated, relapsed myeloma, and has potential to become a new standard of care, an expert said.

Oncology Teamwork With a Personal Touch

May 14th 2022

They work as a team always. In this way, they are always up-to-date on each and every patient’s condition and needs.

An Angel to Patients With Cancer

May 9th 2022

As anyone who has sat at the bedside of a terminally ill patient knows, those who hold out a hand — literally or figuratively — to help a patient and their loved ones is a hero to them.

BCMA-Targeted Drugs Allow for a ‘More Targeted Killing’ of Myeloma Cells

April 13th 2022

In recent years, BCMA-targeted therapies have changed the landscape of relapsed/refractory myeloma treatment, filling a previously unmet need.

COVID-19 and Cancer May Disproportionally Affect Black Patients Compared With Others

April 11th 2022

The results, according to the study authors, may highlight a bigger issue related to structural racism in health care.

Educated Patient® Multiple Myeloma Summit New Therapies on the Horizon Panel: March 12, 2022

April 9th 2022

Watch Kristie L. Kahl, with Sham Mailankody, MBBS; Cesar Rodriguez, MD; and Lynn Steele, discuss new therapies on the horizon, during the CURE Educated Patient Multiple Myeloma Summit.

Highlights from CURE's Educated Patient Multiple Myeloma Summit

April 8th 2022

Here are some key takeaways from the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Upcoming FDA Approvals Presentation: March 12, 2022

April 8th 2022

Watch Dr. Cesar Rodriguez, of the Multiple Myeloma Program at the Ichan School of Medicine at Mount Sinai, discuss upcoming FDA approvals in the space, during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit CAR/BiTE Presentation: March 12, 2022

April 7th 2022

Watch Dr. Sham Mailankody, from Memorial Sloan Kettering Cancer Center, discuss CAR and BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit MM4MM Keynote Lecture: March 12, 2022

April 6th 2022

Watch Dr. Saad Z. Usmani, Dr. Ben Marcus and Stan Wagner discuss their participation in the Moving Mountains for Multiple Myeloma program, during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Myeloma Treating Myeloma Long-Term Panel: March 12, 2022

April 5th 2022

Watch Kristie L. Kahl, Donna and Jack McNutt, Dr. Noopur Raje, and Grace Allison, discuss treating myeloma long term, during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Myeloma Treatment Panel: March 12, 2022

April 4th 2022

Watch Dr. Saad Z. Usmani, Dr. Krina K. Patel, Dr. Noa Biran, and Jenny Ahlstrom, answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Relapsed/Refractory Myeloma Presentation: March 12, 2022

April 3rd 2022

Watch Dr. Noa Biran, an associate professor of medicine in the division of multiple myeloma at The John Theurer Cancer Center at Hackensack University Medical Center, discuss treatment for relapsed/refractory myeloma.

Educated Patient® Multiple Myeloma Summit Newly Diagnosed Myeloma Presentation: March 12, 2022

April 2nd 2022

Watch Dr. Krina K. Patel, an associate professor and center medical director for the Department of Lymphoma-Myeloma at The University of Texas MD Anderson Cancer Center discuss treatment for newly diagnosed myeloma.

Educated Patient® Multiple Myeloma Summit Basics of Myeloma Panel: March 12, 2022

April 1st 2022

Watch Saad Z. Usmani, MD, MBA, with Carlyn Rose Tan, MD; Neha S. Korde, MD; and Kenny Capps answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Risk Stratification for the Newly Diagnosed Presentation: March 12, 2022

March 31st 2022

Watch Dr. Carlyn Rose Tan, an assistant attending in myeloma service at Memorial Sloan Kettering Cancer Center, present on risk stratification for newly diagnosed patients.

NEXT PAGE
PREVIOUS PAGE